CLASS ACTION UPDATE for HL, HRTX and TUSK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Tuesday, July 9, 2019 3:20 PM
NEW YORK, NY / ACCESSWIRE / July 9, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Hecla Mining Company (NYSE: HL)
Class Period: March 19, 2018 - May 8, 2019
Lead Plaintiff Deadline : July 23, 2019
Join the action: https://www.zlk.com/pslra-1/hecla-mining-company-loss-form?prid=2302&wire=1
About the lawsuit: Hecla Mining Company allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (a) the Nevada operations were hemorrhaging cash due to a multitude of material problems identified by Defendants during Hecla’s extensive due diligence of the Nevada mines before the Class Period, and (b) as a result of these material problems, Defendants had no reasonable basis for their representations that the Nevada operations would be in a position to have positive or self-funding cash flow.
To learn more about the Hecla Mining Company class action contact [email protected].
Heron Therapeutics, Inc. (NASDAQ: HRTX)
Class Period: October 31, 2018 - April 30, 2019
Lead Plaintiff Deadline : August 5, 2019
Join the action: https://www.zlk.com/pslra-1/heron-therapeutics-inc-loss-form?prid=2302&wire=1
About the lawsuit: During the class period, Heron Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011; (ii) the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011; and (iii) as a result, Heron’s public statements were materially false and misleading at all relevant times.
To learn more about the Heron Therapeutics, Inc. class action contact [email protected].
Mammoth Energy Services, Inc. (NASDAQ: TUSK)
Class Period: October 19, 2017 - June 5, 2019
Lead Plaintiff Deadline : August 9, 2019
Join the action: https://www.zlk.com/pslra-1/mammoth-energy-services-inc-loss-form?prid=2302&wire=1
About the lawsuit: Throughout the class period, Mammoth Energy Services, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Mammoth’s subsidiary, Cobra, improperly obtained two infrastructure contracts with PREPA that totaled over $1.8 billion; (2) specifically, the contracts were awarded as the result of improper steering and not a competitive RFP process; and (3) as a result, Defendants’ statements about Mammoth’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Mammoth Energy Services, Inc. class action contact [email protected].
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE: Levi & Korsinsky, LLP